tiprankstipranks

Roche upgraded to Buy from Neutral at UBS

Roche upgraded to Buy from Neutral at UBS

UBS upgraded Roche (RHHBY) to Buy from Neutral with a price target of CHF 338, up from CHF 300. The company offers sustainable growth with margin leverage, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue